What Every Cancer Patient Needs to KnowBy ENVITA MEDICAL CENTER
Cancer – it's the scariest, most deadly and most misunderstood of diseases. Even as medical technology makes great strides toward cures, cancer still remains one of the world's leading causes of death.
But there is hope, and it lies in education. Our medical clinic has compiled a list of important guidelines for every cancer patient to understand. Many of these ground-breaking approaches and treatments are completely ignored or used improperly by modern oncologists, but as you'll learn, these strategies are essential to proper cancer treatment.
Every component needs to be customized for each patient, as there is no "one size fits all" to cancer treatment. Various combinations that are personalized give our patients a great advantage to overall care and these unique and targeted methods represent over a decade of our clinical experience.
Genetically Targeted Fractionated Chemotherapy
Most cancer clinics have a "one-size fits all" approach to cancers, but because each tumor is unique (based on specific genetics in the cancer itself, markers on the surface of cancer cells and epigenetic environment around the cancer cells toxins, infections, deficiencies and inflammation factors that cause cancers to spread and mutate) this approach fails to answer the bigger question.
That's where Genetically Targeted Fractionated Chemotherapy comes in. In short, GTFC™ is an advanced form of chemotherapy that applies molecular profiles, genetic typing and targeted treatment, providing patients with much needed alternatives. This method allows us to use multiple drugs in lower dosages to help reduce resistance, enhance targeting while reducing harmful side effects and improve overall treatment.
Immunotherapy is defined as the "treatment of disease by inducing, enhancing, or suppressing an immune response," using immunomodulators, particularly cellular signaling molecules like cytokines. Some immunotherapies activate the immune system, while others suppress it, depending on the situation.
In cancer immunotherapy, the aim is to build the immune system to fight tumors and prevent metastasis, or the spread of cancer. In the 1980's, the National Health Institute published an article detailing their combination of immuno cell therapy with specific chemotherapy regimens. They stated that this combo would be the future of cancer immunotherapy.
Learn about the critical science of cancer cell vaccines and the importance of Natural Killer cells in cancer, plus how immunotherapy offers a completely independent approach to cancer than chemotherapy. This combination with targeted chemotherapy can reduce cancer resistance.
Intravenous Nutritional Therapy
Nutritional deficiencies can lead to a serious amount of health issues. These problems can become exponential in cancer patients because of the severe strain placed on the patient, especially when chemotherapy is involved.
To make matters worse, absorption of vitamins and minerals is impaired. This means, eating a balanced diet and swallowing a few vitamins won't even come close to the nutritional needs of the patient. These changes are essential for long-term health, but in the wake of cancer, it's hardly enough.
What needs to be done is intravenous nutritional therapy. When nutrients are channeled directly into the bloodstream, the results are immediate, targeted and dramatic.
In Latin, the word "inflammation" means "I ignite, set alight" and like gasoline, that's exactly what it does to cancer. A microenvironment of chronic inflammation can increase the risk of cancer, bolster chemotherapy resistance and turn on oncogenes, genes that can turn cells into tumors.
Inflammation can become chronic if the cause of the inflammation persists or certain control mechanisms in charge of shutting down the process fail. When these inflammatory responses become chronic, cell mutation and proliferation can result, often creating an environment that is conducive to the development of cancer. The so-called "perfect storm" is an extreme challenge that cancer patients face.
Oxygen Metabolism in Cancer
One of the main keys of understanding, treating and ultimately winning the raging war against cancer is none other than oxygen. Eighth on the periodic table, oxygen is responsible for the breathing of cells and plays an essential role in providing energy. However, cancerous, mutated cells thrive in anaerobic or oxygen-lacking environments.
One of the main keys of understanding, treating and ultimately winning the raging war against cancer is none other than oxygen. Eighth on the periodic table, oxygen is responsible for the breathing of cells and are essential role in providing energy. However, cancerous, mutated cells thrive in anaerobic, or oxygen-lacking environments.
If you have any questions about your individual medical situation please don't hesitate to contact us.
Over 15 years of specialization in late-stage and complex cancers has finally revealed the best strategies for doctors to bring forth better results with patients. This article aim...
Why didn't my chemotherapy work? This is a question that many cancer patients know all too well, but why are patients becoming unresponsive to chemotherapy? What can be done to dra...
Immunotherapy is the new hot-topic in cancer treatment discussions, but what exactly is it? Immunotherapy is a cancer treatment designed to boost the body's natural ability to figh...
Imagine yourself on chemotherapy and your drugs at first seem to be helping you win your fight against cancer – but you're also incredibly weak, your immunity is shot and now, your...
Cancer – it's the scariest, most deadly and most misunderstood of diseases. Even as medical technology makes great strides toward cures, cancer still remains one of the world's lea...
 Blue Cross Blue Evaluation. Pharmacogenomics of Cancer-Candidate Genes. Assessment Program (2007), Vol. 22, no. 5.Weinshilboum, Richard. Review of genomics Inheritance and Drug Response. New England Journal of Medicine (2003), Vol. 348, no. 6, 529-537.
 Wu, Xifeng, Gu, Jian, et al. Genetic Variations in Radiation and Chemotherapy Drug Action Pathways Predict Clinical Outcomes in Esophageal Cancer. Journal of Clinical Oncology (2006), Vol 24, No. 23, 3789-3798.Evans, William E. and Relling, Mary V. Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics. Science (1999), Vol. 286, no. 5439, 487-491.
 Khew-Voon Chin, et al. Application of Expression Genomics for Predicting Treatment Response in Cancer. Therapeutic Oligonucleotides (2005), Vol 1058: 186-195.
 *An expert on chronic lymphocytic leukemia, Dr. Faguet received his MD degree in Bogota, Colombia and completed his postgraduate work at the University of Texas and Ohio State University. For 28 years he conducted cancer research in Augusta, Georgia that was funded mainly by the National Cancer Institute and the Department of Veterans Affairs. He's written 140 peer-reviewed articles, seven book chapters and two scientific books on cancer.